We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Is Cerazette the minipill of choice?
- Abstract
Around 5% of women aged 16-49 years in Great Britain use a progestogen-only pill (POP; 'minipill') as contraception. These pills are used as alternatives to combined oral contraceptives (COCs), compared to which they are less reliable at preventing pregnancy: the estimated contraceptive failure rate of POPs is 0.5 pregnancies per 100 woman-years when used consistently and correctly, compared with 0.1 per 100 woman-years for COCs. Cerazette (Organon), a new POP, is being promoted by the company as "the first oestrogen free pill to consistently inhibit ovulation", as having "the efficacy of a combined pill, with the reassurance of an oestrogen free pill" and offering "reliable contraception for women of any reproductive age". Here, we consider whether Cerazette offers advantages over established POPs.
- Publication
Drug and therapeutics bulletin, 2003, Vol 41, Issue 9, p68
- ISSN
0012-6543
- Publication type
Journal Article
- DOI
10.1136/dtb.2003.41968